Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 82009-010

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 82009-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pantocontlabel20mg-90s-count (Pantocontlabel20mg 90s Count)

Label for PANTOPRAZOLE SODIUM Delayed-Release Tablets USP 20 mg by Quallent Pharmaceuticals Health LLC. The label indicates 90 tablets per container and includes dosing instructions to see the package insert, storage conditions (20° to 25°C), and warnings against splitting, chewing, or crushing tablets. It features a barcode, batch coding area, and manufacturer details including Hetero Labs Limited in India.*

FDA Label Image

Pantocontlabel40mg-1000s-count (Pantocontlabel40mg 1000s Count)

Label for Pantoprazole Sodium Delayed-Release Tablets USP 40 mg by Quallent Pharmaceuticals Health LLC. Contains 1000 tablets with instructions to dispense the Medication Guide to each patient. Includes storage conditions, contact information, and manufacturer details (Hetero Labs Limited, India).*

FDA Label Image

Pantocontlabel40mg-90s-count (Pantocontlabel40mg 90s Count)

Label for Pantoprazole Sodium Delayed-Release Tablets USP 40 mg by Quallent Pharmaceuticals Health LLC. The label states it contains 90 tablets, includes dosage instructions, storage conditions (20° to 25°C), and a warning not to split, chew, or crush the tablets. Barcode and manufacturing details are also present.*

FDA Label Image

Quallent-logo1 (Quallent Logo1)

FDA Label Image

Quallent-logo2 (Quallent Logo2)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole sodium, the active ingredient in PANTOPRAZOLE SODIUM delayed-release tablets. The structure includes the sodium salt form with typical molecular components and hydration indicated as 1.5 H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.